2,417 Shares of Intuitive Surgical, Inc. $ISRG Bought by Formidable Asset Management LLC

Formidable Asset Management LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,417 shares of the medical equipment provider’s stock, valued at approximately $961,000.

A number of other hedge funds have also added to or reduced their stakes in ISRG. North Point Portfolio Managers Corp OH bought a new stake in Intuitive Surgical during the third quarter worth $27,000. John Boyer Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter valued at $27,000. Compass Wealth Management LLC purchased a new stake in Intuitive Surgical in the 3rd quarter valued at $29,000. Main Street Group LTD bought a new position in Intuitive Surgical during the 1st quarter valued at $30,000. Finally, Compass Financial Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $452.80 on Monday. The business’s fifty day moving average price is $409.93 and its 200-day moving average price is $431.89. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The stock has a market capitalization of $156.96 billion, a PE ratio of 54.75, a P/E/G ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.40 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, SVP Patricia Wadors sold 1,078 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president owned 881 shares in the company, valued at $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 49,128 shares of company stock valued at $21,614,167. 0.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Wells Fargo & Company reissued an “overweight” rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. UBS Group reiterated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 13th. Stifel Nicolaus cut their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Intuitive Surgical Profile